Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma

Increasing incidence coupled with poor prognosis and treatments that are virtually unchanged over the past 20 years have made the need for the development of novel therapeutics for hepatoblastoma imperative. PIM kinases have been implicated as drivers of tumorigenesis in multiple cancers, including...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Stafman, Laura L., Mruthyunjayappa, Smitha, Waters, Alicia M., Garner, Evan F., Aye, Jamie M., Stewart, Jerry E., Yoon, Karina J., Whelan, Kimberly, Mroczek-Musulman, Elizabeth, Beierle, Elizabeth A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2018
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5978256/
https://ncbi.nlm.nih.gov/pubmed/29854306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25205
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items